Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Sarah Parker

Concepts (344)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antimicrobial Stewardship
11
2021
129
4.550
 Why?
Hospitals, Pediatric
22
2022
555
3.520
 Why?
Anti-Infective Agents
12
2021
242
3.400
 Why?
Anti-Bacterial Agents
34
2024
1906
2.970
 Why?
Bacteremia
4
2025
221
2.120
 Why?
Osteomyelitis
9
2024
143
2.060
 Why?
Arthritis, Infectious
7
2022
72
1.900
 Why?
Drug Utilization Review
6
2020
61
1.570
 Why?
Bacterial Infections
7
2025
246
1.410
 Why?
Blood Culture
4
2025
25
1.390
 Why?
Metronidazole
3
2019
20
1.200
 Why?
Appendicitis
3
2019
148
1.070
 Why?
Child
50
2026
22537
1.020
 Why?
Staphylococcal Infections
5
2025
388
1.010
 Why?
Otitis Media
4
2024
181
1.000
 Why?
Acute Disease
8
2025
1028
0.930
 Why?
Kingella kingae
2
2022
12
0.860
 Why?
Intensive Care Units, Neonatal
2
2025
279
0.840
 Why?
Respiration, Artificial
3
2026
707
0.810
 Why?
Retrospective Studies
27
2025
17009
0.710
 Why?
Methicillin-Resistant Staphylococcus aureus
3
2025
248
0.700
 Why?
Musculoskeletal System
1
2022
49
0.690
 Why?
Musculoskeletal Diseases
2
2025
88
0.680
 Why?
Surgical Wound Infection
2
2022
316
0.650
 Why?
Humans
75
2026
144261
0.580
 Why?
Infant
22
2026
10022
0.570
 Why?
Respiratory Tract Infections
1
2022
396
0.540
 Why?
Interdisciplinary Communication
1
2019
197
0.540
 Why?
Drug Resistance, Bacterial
3
2021
196
0.530
 Why?
Medical Order Entry Systems
1
2018
40
0.530
 Why?
Cefoxitin
1
2017
8
0.520
 Why?
Gram-Negative Bacterial Infections
1
2017
51
0.510
 Why?
Cephalosporins
2
2015
47
0.510
 Why?
Ceftriaxone
1
2017
21
0.510
 Why?
Microbial Sensitivity Tests
5
2024
370
0.510
 Why?
Child, Preschool
19
2026
11774
0.510
 Why?
beta-Lactams
1
2017
32
0.500
 Why?
Gram-Positive Bacterial Infections
1
2017
69
0.500
 Why?
Interprofessional Relations
1
2019
280
0.490
 Why?
Prescriptions
1
2016
76
0.480
 Why?
Pneumonia, Bacterial
1
2017
113
0.480
 Why?
Drug Costs
1
2017
115
0.480
 Why?
Pyomyositis
3
2022
15
0.480
 Why?
Communicable Diseases
4
2021
163
0.470
 Why?
Exanthema
1
2016
84
0.460
 Why?
Neutropenia
1
2016
155
0.450
 Why?
Diarrhea
1
2016
192
0.440
 Why?
Thimerosal
2
2005
6
0.440
 Why?
Mycobacterium tuberculosis
4
2021
334
0.440
 Why?
Health Resources
1
2016
129
0.430
 Why?
Preservatives, Pharmaceutical
2
2005
26
0.430
 Why?
Enterovirus D, Human
1
2016
87
0.420
 Why?
Inpatients
4
2021
542
0.420
 Why?
Decision Support Systems, Clinical
1
2018
265
0.410
 Why?
Disease Outbreaks
2
2021
422
0.400
 Why?
Enterovirus Infections
1
2016
173
0.390
 Why?
Cephalexin
2
2024
14
0.390
 Why?
Electronic Health Records
2
2019
1169
0.390
 Why?
Inappropriate Prescribing
1
2013
63
0.380
 Why?
Guideline Adherence
1
2017
586
0.380
 Why?
Pandemics
2
2022
1682
0.380
 Why?
Cross Infection
3
2025
262
0.370
 Why?
Trachea
2
2026
261
0.360
 Why?
Intensive Care Units, Pediatric
3
2025
284
0.340
 Why?
Health Personnel
1
2018
742
0.340
 Why?
Referral and Consultation
1
2017
847
0.330
 Why?
Vancomycin
2
2023
93
0.330
 Why?
Liver Abscess, Amebic
2
2009
3
0.310
 Why?
Phospholipases A
2
2007
98
0.300
 Why?
Urinary Tract Infections
2
2025
202
0.300
 Why?
Practice Guidelines as Topic
1
2017
1559
0.300
 Why?
Stomach Rupture
1
2009
3
0.300
 Why?
Phospholipases
1
2009
14
0.290
 Why?
Thiolester Hydrolases
1
2009
13
0.290
 Why?
Pericardial Effusion
1
2009
22
0.290
 Why?
Male
27
2025
72035
0.280
 Why?
Lactones
1
2009
57
0.280
 Why?
Peritonitis
1
2009
84
0.280
 Why?
Staphylococcus aureus
5
2024
454
0.280
 Why?
Pleural Effusion
1
2009
60
0.280
 Why?
Diphtheria-Tetanus-Pertussis Vaccine
2
2005
27
0.270
 Why?
Drug Utilization
3
2017
166
0.270
 Why?
Colorado
4
2020
4562
0.270
 Why?
Cefadroxil
2
2024
8
0.260
 Why?
Carboxylic Ester Hydrolases
1
2007
23
0.260
 Why?
Gene Expression Regulation, Bacterial
2
2009
327
0.250
 Why?
Cost Savings
2
2017
86
0.250
 Why?
Female
24
2025
77976
0.250
 Why?
Time Factors
4
2024
7155
0.250
 Why?
Dermatomycoses
1
2006
8
0.240
 Why?
Pharmacy Service, Hospital
2
2017
81
0.240
 Why?
Infant, Newborn
7
2025
6424
0.240
 Why?
Adolescent
15
2025
22281
0.230
 Why?
Drug Approval
1
2006
89
0.230
 Why?
Mycobacterium
1
2007
116
0.230
 Why?
Immunoglobulins, Intravenous
1
2006
126
0.230
 Why?
Infection Control
3
2015
171
0.220
 Why?
Intellectual Property
1
2005
7
0.220
 Why?
Autistic Disorder
2
2005
210
0.220
 Why?
Measles
1
2025
46
0.220
 Why?
Specimen Handling
1
2026
185
0.210
 Why?
Mycoses
1
2025
88
0.210
 Why?
Simplexvirus
1
2004
82
0.210
 Why?
Encephalitis, Viral
1
2004
45
0.210
 Why?
Limbus Corneae
1
2023
8
0.200
 Why?
Bacterial Proteins
2
2018
954
0.200
 Why?
Amoxicillin
1
2024
35
0.200
 Why?
Herpes Simplex
1
2004
98
0.200
 Why?
Lymphadenitis
1
2023
6
0.190
 Why?
Drug Administration Schedule
3
2017
778
0.190
 Why?
Hospitalization
5
2023
2424
0.190
 Why?
Cisplatin
1
2024
334
0.190
 Why?
Drainage
2
2017
185
0.190
 Why?
Extracellular Vesicles
1
2025
170
0.190
 Why?
Exosomes
1
2023
104
0.190
 Why?
Databases, Factual
4
2025
1484
0.180
 Why?
Exudates and Transudates
1
2021
12
0.180
 Why?
Machine Learning
2
2025
585
0.180
 Why?
Cross-Over Studies
1
2024
600
0.170
 Why?
Immunotherapy
1
2006
652
0.170
 Why?
Fluoroquinolones
1
2021
44
0.170
 Why?
Risk Adjustment
1
2021
85
0.170
 Why?
Fever
2
2017
311
0.160
 Why?
Antibiotic Prophylaxis
1
2022
129
0.160
 Why?
Mucocutaneous Lymph Node Syndrome
1
2021
91
0.160
 Why?
Bone Diseases, Infectious
1
2020
8
0.160
 Why?
Hospitals
3
2021
727
0.160
 Why?
Delayed Diagnosis
1
2021
94
0.160
 Why?
Treatment Outcome
7
2024
11643
0.160
 Why?
Meningitis
1
2021
80
0.160
 Why?
Laboratories
1
2021
109
0.160
 Why?
Molecular Diagnostic Techniques
2
2020
104
0.160
 Why?
Bacteroides fragilis
1
2019
14
0.150
 Why?
Encephalitis
1
2021
139
0.150
 Why?
Appendectomy
2
2017
89
0.150
 Why?
Monte Carlo Method
1
2019
155
0.150
 Why?
Drug Resistance, Neoplasm
1
2024
881
0.150
 Why?
Autophagy
1
2021
285
0.150
 Why?
Neisseriaceae Infections
1
2018
6
0.150
 Why?
Pediatrics
3
2017
1112
0.150
 Why?
Area Under Curve
1
2019
329
0.140
 Why?
Entamoeba histolytica
2
2009
10
0.140
 Why?
Antibodies, Monoclonal
1
2006
1519
0.140
 Why?
Hospital Records
1
2018
10
0.140
 Why?
Reactive Oxygen Species
1
2021
621
0.140
 Why?
Drug Therapy, Combination
2
2021
1044
0.140
 Why?
Proteomics
1
2025
1191
0.140
 Why?
Induced Pluripotent Stem Cells
1
2021
276
0.140
 Why?
Medical Records Systems, Computerized
1
2018
95
0.140
 Why?
Hydrolysis
2
2009
198
0.130
 Why?
Tuberculosis
1
2021
289
0.130
 Why?
Sequence Homology, Amino Acid
2
2009
396
0.130
 Why?
Combined Modality Therapy
2
2017
1264
0.130
 Why?
Patient Readmission
3
2017
756
0.130
 Why?
MicroRNAs
1
2023
700
0.130
 Why?
Abdominal Abscess
1
2017
25
0.130
 Why?
Abscess
1
2017
75
0.130
 Why?
Central Venous Catheters
1
2017
52
0.130
 Why?
Medical Records
1
2017
186
0.120
 Why?
Administration, Oral
2
2016
847
0.120
 Why?
Communicable Disease Control
1
2017
86
0.120
 Why?
Drug Substitution
1
2017
63
0.120
 Why?
Drug Resistance
1
2017
153
0.120
 Why?
Pharmacists
1
2019
240
0.120
 Why?
Amino Acid Sequence
4
2009
2154
0.120
 Why?
Osteoarthritis
1
2018
195
0.120
 Why?
Drug Prescriptions
1
2018
280
0.120
 Why?
Rural Population
1
2021
648
0.120
 Why?
Molecular Sequence Data
4
2009
2929
0.120
 Why?
Aftercare
1
2017
220
0.120
 Why?
Sensitivity and Specificity
3
2025
1983
0.110
 Why?
Administration, Intravenous
1
2016
170
0.110
 Why?
Cell Wall
2
2021
61
0.110
 Why?
Length of Stay
2
2020
1335
0.110
 Why?
Community-Acquired Infections
1
2017
174
0.110
 Why?
United States
9
2025
15876
0.110
 Why?
Knowledge Management
1
2014
2
0.110
 Why?
Radiography
1
2017
842
0.110
 Why?
Diabetes Mellitus
1
2023
1092
0.110
 Why?
Clostridium Infections
1
2015
74
0.110
 Why?
Prospective Studies
3
2024
7970
0.100
 Why?
Medication Therapy Management
1
2014
73
0.100
 Why?
Cost-Benefit Analysis
1
2017
623
0.100
 Why?
Postoperative Care
1
2016
288
0.100
 Why?
Antitubercular Agents
2
2021
215
0.100
 Why?
Antineoplastic Agents
1
2024
2192
0.100
 Why?
Acute Kidney Injury
1
2021
862
0.100
 Why?
Tomography, X-Ray Computed
3
2009
2730
0.100
 Why?
Drug Monitoring
1
2016
389
0.090
 Why?
Ambulatory Care
1
2017
597
0.090
 Why?
Genotype
3
2021
1833
0.090
 Why?
Quality of Health Care
1
2017
688
0.090
 Why?
Risk Assessment
2
2016
3637
0.090
 Why?
Drug Hypersensitivity
1
2013
90
0.090
 Why?
Laparoscopy
1
2017
475
0.090
 Why?
Bacteria
3
2023
889
0.090
 Why?
Physicians
1
2019
938
0.080
 Why?
Cohort Studies
2
2017
5935
0.080
 Why?
Patient Education as Topic
1
2014
777
0.080
 Why?
Paromomycin
1
2009
3
0.070
 Why?
Young Adult
4
2021
13990
0.070
 Why?
Mycolic Acids
1
2009
7
0.070
 Why?
Trophozoites
1
2009
4
0.070
 Why?
Attitude of Health Personnel
1
2017
1182
0.070
 Why?
Antiprotozoal Agents
1
2009
15
0.070
 Why?
Practice Patterns, Physicians'
1
2018
1347
0.070
 Why?
DNA, Protozoan
1
2008
32
0.070
 Why?
Dose-Response Relationship, Drug
2
2017
2026
0.070
 Why?
Tuberculosis, Pulmonary
1
2009
131
0.070
 Why?
Nitrobenzenes
1
2007
17
0.070
 Why?
Chromatography, Thin Layer
1
2007
27
0.070
 Why?
Polysorbates
1
2007
42
0.060
 Why?
Cell Line, Tumor
2
2025
3539
0.060
 Why?
Terminology as Topic
1
2009
255
0.060
 Why?
Injections, Intravenous
2
2017
200
0.060
 Why?
Gentian Violet
1
2026
4
0.060
 Why?
Membrane Lipids
1
2007
83
0.060
 Why?
Phenazines
1
2026
16
0.060
 Why?
Animals
6
2024
38030
0.060
 Why?
Selection, Genetic
1
2008
256
0.060
 Why?
Maximum Tolerated Dose
1
2006
212
0.060
 Why?
Recombinant Proteins
1
2009
1367
0.060
 Why?
Measles Vaccine
1
2025
18
0.060
 Why?
United States Food and Drug Administration
1
2006
203
0.060
 Why?
Enzyme Inhibitors
1
2009
824
0.060
 Why?
Aminopeptidases
1
2024
21
0.050
 Why?
Ethylmercury Compounds
1
2004
1
0.050
 Why?
Risk Factors
2
2016
10699
0.050
 Why?
Diphtheria-Tetanus Vaccine
1
2004
5
0.050
 Why?
Methylmercury Compounds
1
2004
8
0.050
 Why?
Drug Industry
1
2005
48
0.050
 Why?
Aphasia
1
2004
24
0.050
 Why?
Mass Spectrometry
2
2025
744
0.050
 Why?
Diagnosis, Differential
1
2009
1487
0.050
 Why?
Half-Life
1
2004
151
0.050
 Why?
Patient Discharge
2
2025
977
0.050
 Why?
North America
1
2025
310
0.050
 Why?
Streptococcus pyogenes
1
2004
41
0.050
 Why?
Amoxicillin-Potassium Clavulanate Combination
1
2024
16
0.050
 Why?
Acyclovir
1
2004
96
0.050
 Why?
Escherichia coli
1
2009
852
0.050
 Why?
Adult
5
2021
40262
0.050
 Why?
Child Development Disorders, Pervasive
1
2004
62
0.050
 Why?
Hematologic Neoplasms
1
2006
161
0.050
 Why?
Reproducibility of Results
2
2023
3403
0.050
 Why?
Vomiting
1
2004
130
0.050
 Why?
beta-Lactamases
1
2024
51
0.050
 Why?
Kinetics
1
2007
1627
0.050
 Why?
Sulbactam
1
2023
6
0.050
 Why?
Ampicillin
1
2023
15
0.050
 Why?
Stromal Cells
1
2023
124
0.050
 Why?
Nasopharynx
1
2023
73
0.050
 Why?
Haemophilus influenzae
1
2023
67
0.050
 Why?
Multiplex Polymerase Chain Reaction
1
2023
53
0.050
 Why?
Pneumonia
1
2009
630
0.050
 Why?
Cephalothin
1
2022
5
0.050
 Why?
Oxacillin
1
2022
5
0.050
 Why?
Type C Phospholipases
1
2002
69
0.050
 Why?
Methicillin
1
2022
10
0.050
 Why?
Cefazolin
1
2022
22
0.050
 Why?
Cornea
1
2023
155
0.050
 Why?
Butanes
1
2021
4
0.040
 Why?
Cell Extracts
1
2021
21
0.040
 Why?
DNA Glycosylases
1
2021
9
0.040
 Why?
Single-Cell Analysis
1
2025
356
0.040
 Why?
Gestational Age
1
2025
975
0.040
 Why?
Cell Communication
1
2023
324
0.040
 Why?
Ubiquinone
1
2021
35
0.040
 Why?
Pyridinium Compounds
1
2021
31
0.040
 Why?
Streptococcus pneumoniae
1
2023
177
0.040
 Why?
Autophagy-Related Proteins
1
2021
46
0.040
 Why?
Developmental Disabilities
1
2004
281
0.040
 Why?
Megakaryocytes
1
2021
34
0.040
 Why?
Arkansas
1
2021
21
0.040
 Why?
Reference Standards
1
2021
177
0.040
 Why?
Microbiology
1
2021
24
0.040
 Why?
Organophosphorus Compounds
1
2021
84
0.040
 Why?
Seizures
1
2004
460
0.040
 Why?
Staining and Labeling
1
2021
150
0.040
 Why?
NLR Family, Pyrin Domain-Containing 3 Protein
1
2021
169
0.040
 Why?
Drug Combinations
1
2021
390
0.040
 Why?
Ubiquitin-Protein Ligases
1
2021
192
0.040
 Why?
Pseudomonas aeruginosa
1
2002
356
0.040
 Why?
Myositis
1
2020
57
0.040
 Why?
Coronary Vessels
1
2021
251
0.040
 Why?
Diagnostic Errors
1
2020
175
0.040
 Why?
Neoplasms
2
2025
2870
0.040
 Why?
Clindamycin
1
2018
14
0.040
 Why?
Feces
2
2015
513
0.040
 Why?
Developed Countries
1
2018
37
0.040
 Why?
Gene Expression Regulation, Neoplastic
1
2024
1455
0.030
 Why?
Hospital Charges
1
2018
46
0.030
 Why?
Cross-Sectional Studies
2
2021
5813
0.030
 Why?
Leukocytes, Mononuclear
1
2021
573
0.030
 Why?
Methyltransferases
1
2018
74
0.030
 Why?
Bacteriological Techniques
1
2018
68
0.030
 Why?
Research Design
1
2004
1129
0.030
 Why?
Medical Staff, Hospital
1
2018
80
0.030
 Why?
Prostatic Neoplasms
1
2025
974
0.030
 Why?
Metformin
1
2021
315
0.030
 Why?
Controlled Before-After Studies
1
2017
15
0.030
 Why?
Age Distribution
1
2018
397
0.030
 Why?
Sex Distribution
1
2018
380
0.030
 Why?
Blood Platelets
1
2021
399
0.030
 Why?
Epithelial Cells
1
2023
1125
0.030
 Why?
Arthritis, Rheumatoid
1
2006
1168
0.030
 Why?
Benchmarking
1
2018
188
0.030
 Why?
Vaccination
1
2025
1422
0.030
 Why?
Mice
2
2021
18329
0.030
 Why?
Myocardium
1
2021
939
0.030
 Why?
Comorbidity
1
2021
1646
0.030
 Why?
Genomics
1
2021
833
0.030
 Why?
Early Diagnosis
1
2016
247
0.030
 Why?
Lung
1
2009
4108
0.030
 Why?
Algorithms
1
2023
1834
0.030
 Why?
Asthma
1
2006
1767
0.030
 Why?
Recurrence
1
2017
1134
0.030
 Why?
Alcoholism
1
2021
808
0.030
 Why?
Inservice Training
1
2014
116
0.030
 Why?
Polymorphism, Single Nucleotide
1
2021
2143
0.020
 Why?
Kidney
1
2021
1495
0.020
 Why?
Cell Differentiation
1
2021
2048
0.020
 Why?
Substrate Specificity
2
2004
388
0.020
 Why?
Medical Oncology
1
2015
331
0.020
 Why?
Brain
1
2004
2930
0.020
 Why?
Hypoglycemic Agents
1
2021
1379
0.020
 Why?
Disease Models, Animal
1
2021
4556
0.020
 Why?
Dysentery, Amebic
1
2008
2
0.020
 Why?
Surveys and Questionnaires
1
2021
6021
0.020
 Why?
Case-Control Studies
1
2015
3592
0.020
 Why?
Polymerase Chain Reaction
1
2008
1054
0.010
 Why?
Prophages
1
2004
9
0.010
 Why?
Postoperative Complications
1
2016
2916
0.010
 Why?
Structure-Activity Relationship
1
2004
567
0.010
 Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
1
2002
143
0.010
 Why?
Electrophoresis, Polyacrylamide Gel
1
2002
330
0.010
 Why?
Choline
1
2002
136
0.010
 Why?
Alleles
1
2004
878
0.010
 Why?
Phospholipids
1
2002
211
0.010
 Why?
Hemolysis
1
2002
243
0.010
 Why?
Base Sequence
1
2004
2187
0.010
 Why?
Calcium
1
2002
1182
0.010
 Why?
Aged
1
2009
25850
0.000
 Why?
Middle Aged
1
2009
35762
0.000
 Why?
Parker's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (344) concept(s)
_
Co-Authors Expand Description
See all (57) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)